Hubei Jumpcan Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 1.88 B

Hubei Jumpcan Pharmaceutical Co., Ltd. Shareholders' Equity is USD 1.88 B for the year ending December 31, 2023, a 14.45% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Hubei Jumpcan Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 1.64 B, a 14.50% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 1.43 B, a 20.64% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 1.19 B, a 35.67% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 876.60 M, a 10.46% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shanghai Stock Exchange: 600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

CEO	Mr. Fei Cao
IPO Date	Aug. 22, 2001
Location	China
Headquarters	Baota Bay
Employees	5,230
Sector	Health Care
Industries Pharmaceuticals

Description

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis. The company was formerly known as Hubei Hongcheng General Machinery Co., Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co., Ltd. in March 2015. Hubei Jumpcan Pharmaceutical Co., Ltd. is based in Taixing, China.

Key trends

Past 5 years